Activating antiviral immune responses potentiates immune checkpoint inhibition in glioblastoma models
Journal of Clinical Investigation · 17.03.2025 · 135 (6)
DOI: 10.1172/jci183745 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 17.03.2025. Verfasst von Deepa Seetharam und 35 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery and. Hauptthemen laut MEDLINE: Glioblastoma, Immune Checkpoint Inhibitors, Immunity, Innate, Brain Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NINDS NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Viral mimicry refers to the activation of innate antiviral immune responses due to the induction of endogenous retroelements (REs). Viral mimicry augments antitumor immune responses and sensitizes solid tumors to immunotherapy. Here, we found that targeting what we believe to be a novel, master epigenetic regulator, Zinc Finger Protein 638 (ZNF638), induces viral mimicry in glioblastoma (GBM) preclinical models and potentiates immune checkpoint inhibition (ICI). ZNF638 recruits the HUSH complex, which precipitates repressive H3K9me3 marks on endogenous REs. In GBM, ZNF638 is associated with marked locoregional immunosuppressive transcriptional signatures, reduced endogenous RE expression, and poor immune cell infiltration. Targeting ZNF638 decreased H3K9 trimethylation, increased REs, and activated intracellular dsRNA signaling cascades. Furthermore, ZNF638 knockdown upregulated antiviral immune programs and significantly increased PD-L1 immune checkpoint expression in diverse GBM models. Importantly, targeting ZNF638 sensitized mice to ICI in syngeneic murine orthotopic models through innate IFN signaling. This response was recapitulated in recurrent GBM (rGBM) samples with radiographic responses to checkpoint inhibition with widely increased expression of dsRNA, PD-L1, and perivascular CD8 cell infiltration, suggesting that dsRNA signaling may mediate response to immunotherapy. Finally, low ZNF638 expression was a biomarker of clinical response to ICI and improved survival in patients with rGBM and patients with melanoma. Our findings suggest that ZNF638 could serve as a target to potentiate immunotherapy in gliomas.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery and.
- Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, Florida, USA.
- National Institute of Neurological Disorders and Stroke, NIH, Bethesda, Maryland, USA.
- Department of Neurological Surgery and.
- Northwestern Medicine Malnati Brain Tumor Institute of the Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
- Desai Sethi Urology Institute University of Miami, Miller School of Medicine, Miami, Florida, USA.
Förderung
- NCI NIH HHS
- NINDS NIH HHS
- National Institutes of Health
- Elsa Pardee Foundation
- UM American Cancer Society Intramural Funding
- Florida Center for Brain Tumor Research
- Neurosurgery Research and Education Foundation
- Dwoskin Family Fund
Zitieren
APA
Seetharam, D., Chandar, J., Ramsoomair, C. K., Desgraves, J. F., Alvarado Medina, A., Hudson, A. J., Amidei, A., Castro, J. R., Govindarajan, V., Wang, S., Zhang, Y., Sonabend, A. M., Mendez Valdez, M. J., Maric, D., Govindarajan, V., Rivas, S. R., Lu, V. M., Tiwari, R., Sharifi, N., …, & Shah, A. H. (2025). Activating antiviral immune responses potentiates immune checkpoint inhibition in glioblastoma models. Journal of Clinical Investigation, 135(6). https://doi.org/10.1172/jci183745
Vancouver
Seetharam D, Chandar J, Ramsoomair CK, Desgraves JF, Alvarado Medina A, Hudson AJ, et al. Activating antiviral immune responses potentiates immune checkpoint inhibition in glioblastoma models. Journal of Clinical Investigation. 2025;135(6). doi:10.1172/jci183745
BibTeX
@article{Seetharam2025,
author = {Seetharam, Deepa and Chandar, Jay and Ramsoomair, Christian K and Desgraves, Jelisah F and Alvarado Medina, Alexandra and Hudson, Anna Jane and Amidei, Ava and Castro, Jesus R and Govindarajan, Vaidya and Wang, Sarah and Zhang, Yong and Sonabend, Adam M and Mendez Valdez, Mynor J and Maric, Dragan and Govindarajan, Vasundara and Rivas, Sarah R and Lu, Victor M and Tiwari, Ritika and Sharifi, Nima and Thomas, Emmanuel and Alexander, Marcus and DeMarino, Catherine and Johnson, Kory and De La Fuente, Macarena I and Alshiekh Nasany, Ruham and Noviello, Teresa Maria Rosaria and Ivan, Michael E and Komotar, Ricardo J and Iavarone, Antonio and Nath, Avindra and Heiss, John and Ceccarelli, Michele and Chiappinelli, Katherine B and Figueroa, Maria E and Bayik, Defne and Shah, Ashish H},
title = {Activating antiviral immune responses potentiates immune checkpoint inhibition in glioblastoma models},
journal = {Journal of Clinical Investigation},
year = {2025},
volume = {135},
number = {6},
doi = {10.1172/jci183745}
}
EUVIMED